These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36299300)

  • 21. Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC.
    Olaoba OT; Ligali FC; Alabi ZO; Akinyemi AO; Ayinde KS
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188483. PubMed ID: 33232723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics.
    Ijichi H
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma.
    Ahmad IM; Dafferner AJ; O'Connell KA; Mehla K; Britigan BE; Hollingsworth MA; Abdalla MY
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review.
    Li HB; Yang ZH; Guo QQ
    Cell Commun Signal; 2021 Nov; 19(1):117. PubMed ID: 34819086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How does the tumor microenvironment play a role in hepatobiliary tumors?
    Kamil F; Rowe JH
    J Gastrointest Oncol; 2018 Feb; 9(1):180-195. PubMed ID: 29564184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions.
    Herting CJ; Karpovsky I; Lesinski GB
    Cancer Metastasis Rev; 2021 Sep; 40(3):675-689. PubMed ID: 34591240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia.
    Opitz FV; Haeberle L; Daum A; Esposito I
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
    Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
    Front Immunol; 2021; 12():643529. PubMed ID: 33679807
    [No Abstract]   [Full Text] [Related]  

  • 30. Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential.
    Cannon A; Thompson C; Hall BR; Jain M; Kumar S; Batra SK
    Genes Cancer; 2018 Mar; 9(3-4):78-86. PubMed ID: 30108679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal adenocarcinoma.
    Liu X; Liu J; Xu J; Zhang B; Wei M; Li J; Xu H; Yu X; Wang W; Shi S
    Transl Oncol; 2023 Jan; 27():101561. PubMed ID: 36257208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting both tumour-associated CXCR2
    Nywening TM; Belt BA; Cullinan DR; Panni RZ; Han BJ; Sanford DE; Jacobs RC; Ye J; Patel AA; Gillanders WE; Fields RC; DeNardo DG; Hawkins WG; Goedegebuure P; Linehan DC
    Gut; 2018 Jun; 67(6):1112-1123. PubMed ID: 29196437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanodiamond Mediated Molecular Targeting in Pancreatic Ductal Adenocarcinoma: Disrupting the Tumor-stromal Cross-talk, Next Hope on the Horizon?
    Singh M; Pal P; Dutta RS; Marbaniang D; Ray S; Mazumder B
    Curr Cancer Drug Targets; 2023; 23(8):620-633. PubMed ID: 36843367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future of immunotherapy in pancreas cancer and the trials, tribulations and successes thus far.
    Wong W; Alouani E; Wei A; Ryu YK; Chabot JA; Manji GA
    Semin Oncol; 2021 Feb; 48(1):57-68. PubMed ID: 33965249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photoimmunotherapy Retains Its Anti-Tumor Efficacy with Increasing Stromal Content in Heterotypic Pancreatic Cancer Spheroids.
    Saad MA; Zhung W; Stanley ME; Formica S; Grimaldo-Garcia S; Obaid G; Hasan T
    Mol Pharm; 2022 Jul; 19(7):2549-2563. PubMed ID: 35583476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment.
    Li Y; Zhao W; Wang Y; Wang H; Liu S
    J Nanobiotechnology; 2022 May; 20(1):208. PubMed ID: 35501802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma.
    Zhang J; Li R; Huang S
    Front Oncol; 2022; 12():951019. PubMed ID: 35965504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment.
    Garcia Garcia CJ; Huang Y; Fuentes NR; Turner MC; Monberg ME; Lin D; Nguyen ND; Fujimoto TN; Zhao J; Lee JJ; Bernard V; Yu M; Delahoussaye AM; Jimenez Sacarello I; Caggiano EG; Phan JL; Deorukhkar A; Molkentine JM; Saur D; Maitra A; Taniguchi CM
    Gastroenterology; 2022 Jun; 162(7):2018-2031. PubMed ID: 35216965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translational Learnings in the Development of Chemo-Immunotherapy Combination to Bypass the Cold Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma.
    Kaplon H
    Front Oncol; 2022; 12():835502. PubMed ID: 35664786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma.
    Sperb N; Tsesmelis M; Wirth T
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.